Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy.

Davis NB, Ryan CW, Stadler WM, Vogelzang NJ. A phase II study of nilutamide in men with prostate cancer after the failure of flutamide or bicalutamide therapy. BJU Int. 2005 Oct; 96(6):787-90.

View in: PubMed

collapse authors with profiles